Tehua Pharmaceutical (002728.SZ) issued a forecast of a substantial increase, with an estimated net profit attributable to the parent company of 34-38 million yuan in the first half of the year, representing a year-on-year growth of 1164.22%-1312.95%.

Cnstock News APP reported that Teva Pharmaceuticals (002728.SZ) released its 2025 interim performance forecast. The company expects a net profit attributable to shareholders of listed companies of 34 million to 38 million yuan, a year-on-year increase of 1164.22% to 1312.95%. After deducting non-recurring gains and losses, the net profit is expected to be 31.5 million to 35.5 million yuan, a year-on-year increase of 5024.45% to 5675.17%.